TherageniX and University of Nottingham awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

Funding from Innovate UK’s Transforming Medicines Manufacturing program supporting innovative technologies for intracellular drug delivery.

Targeted therapy improves pregnancy outcomes

Amongst women who experience recurrent pregnancy loss, around 20% test positive for a specific antibody that targets the mother’s own body. A Kobe University-led research

September 26, 2024

Explanations Don’t Help Clinicians Spot Biased AI

Providing clinicians with artificial intelligence (AI) predictions along with model explanations can boost diagnostic accuracy, but that accuracy drops when using a biased AI model

December 20, 2023

Tonix to acquire Upsher-Smith’s migraine products

Zembrace SymTouch and Tosymra offer migraine pain relief onset in 10 minutes. Credit: Usman Yousaf on Unsplash. Tonix Pharmaceuticals and its subsidiary Tonix Medicines have signed

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.